Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis

SIMPLE SUMMARY: In this study, we investigated the impact of immune-related adverse events (irAEs) on the survival of advanced melanoma patients treated with immune-checkpoint inhibitors, as well as the effect of corticosteroids and other immune-modulators on clinical outcome. We summarized the kine...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitriou, Florentia, Staeger, Ramon, Ak, Melike, Maissen, Matias, Kudura, Ken, Barysch, Marjam J., Levesque, Mitchell P., Cheng, Phil F., Dummer, Reinhard, Mangana, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230729/
https://www.ncbi.nlm.nih.gov/pubmed/34208218
http://dx.doi.org/10.3390/cancers13122931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230729/
https://www.ncbi.nlm.nih.gov/pubmed/34208218
http://dx.doi.org/10.3390/cancers13122931

Ejemplares similares